US FDA approves Inovio's treatment for rare throat disease; shares surge Reuters
US FDA approves Inovio's treatment for rare throat disease; shares surge - Reuters
In short
Food and Drug Administration has approved Inovio's treatment for a rare throat disease. Following the regulatory decision, shares of the company experienced a surge.
Key points
- Food and Drug Administration has approved Inovio's treatment for a rare throat disease.: Food and Drug Administration has approved Inovio's treatment for a rare throat disease.
- Following the regulatory decision, shares of the company experienced a surge.: Following the regulatory decision, shares of the company experienced a surge.